Patients with advanced RCC were divided into two groups (high vs. low expression) according to the median expression of FAAH and GPX4 in tumor tissue (Fig. 1A, B and Table 1) and then followed clinically. The gene discussed is GPX4; the disease is renal cell carcinoma.